FILACCHIONI, GUIDO
 Distribuzione geografica
Continente #
NA - Nord America 4.740
EU - Europa 2.718
AS - Asia 601
AF - Africa 42
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 8.106
Nazione #
US - Stati Uniti d'America 4.731
SE - Svezia 646
IE - Irlanda 558
UA - Ucraina 466
DE - Germania 289
IT - Italia 241
VN - Vietnam 212
HK - Hong Kong 208
GB - Regno Unito 175
PL - Polonia 133
FI - Finlandia 124
CN - Cina 74
JO - Giordania 57
FR - Francia 36
SC - Seychelles 34
TR - Turchia 27
CH - Svizzera 14
RU - Federazione Russa 13
BE - Belgio 12
CA - Canada 9
IN - India 9
NL - Olanda 7
JP - Giappone 5
KR - Corea 5
NA - Namibia 4
AT - Austria 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
AU - Australia 1
BR - Brasile 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EU - Europa 1
IR - Iran 1
IS - Islanda 1
MU - Mauritius 1
NG - Nigeria 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 8.106
Città #
Jacksonville 693
Fairfield 600
Dublin 558
Chandler 467
Ashburn 418
Cambridge 289
Seattle 279
Woodbridge 268
Wilmington 241
Dong Ket 212
Houston 173
Warsaw 133
Princeton 121
Ann Arbor 114
Hong Kong 103
Boardman 99
Medford 82
Altamura 65
Boston 64
Lawrence 48
Shanghai 38
Philadelphia 35
San Diego 34
Milan 29
Beijing 27
Frankfurt Am Main 26
Norwalk 25
Buffalo 22
Auburn Hills 21
Washington 15
Hanover 14
Verona 14
Bern 13
Brussels 12
Hillsboro 12
Izmir 12
Andover 10
New York 9
Florence 8
Salerno 8
Düsseldorf 7
Toronto 7
Laurel 6
Los Angeles 6
Mountain View 5
Phoenix 5
Groningen 4
Windhoek 4
Grevenbroich 3
Lappeenranta 3
London 3
Redwood City 3
Venice 3
Auckland 2
Bologna 2
Dallas 2
Edinburgh 2
Falls Church 2
Hefei 2
Khobar 2
Kilburn 2
Marina di Montemarciano 2
Pontelandolfo 2
Tokyo 2
Arnsberg 1
Bangkok 1
Boiling Springs 1
Brisbane 1
Brno 1
Cavarzere 1
Central 1
Chieti 1
Chiswick 1
Chongqing 1
Covington 1
Downey 1
Epsom 1
Frankfurt am Main 1
Fuzhou 1
Hangzhou 1
Hogansville 1
Istanbul 1
Jena 1
Johannesburg 1
Lagos 1
Mcallen 1
Montreal 1
Montréal 1
Mutterstadt 1
Naaldwijk 1
Nagareyama 1
New Delhi 1
Portland 1
Redmond 1
Renens 1
Reykjavik 1
San Jose 1
San Mateo 1
Sanda 1
Santa Maria 1
Totale 5.528
Nome #
The identification of the 2-phenylphthalazin-1(2H)-one scaffold as a new decorable core skeleton for the design of potent and selective human A3 adenosine receptor antagonists. 214
1,2,4-Triazolo[4,3-a]quinoxalin-1-one: a versatile tool for the synthesis of potent and selective adenosine receptor antagonists. 167
The 1,2,4-Triazolo[4,3-a]quinoxalin-1-one Moiety as an Attractive Scaffold to Develop New Potent and Selective Human A3 Adenosine Receptor Antagonists: Synthesis, Pharmacological and Ligand-Receptor Modeling Studies. 160
“1,2,4-TRIAZOLO[1,5-A]QUINOXALINE DERIVATIVES: SYNTHESIS AND BIOLOGICAL EVALUATION AS ADENOSINE RECEPTOR ANTAGONISTS” 140
1,3-DIARYLPYRAZOLO[4,5-C]- AND -[5,4-C]QUINOLIN-4-ONES. 4. SYNTHESIS AND SPECIFIC INHIBITION OF BENZODIAZEPINE RECEPTOR BINDING. 133
1,2,4-Triazolo[1,5-a]quinoxaline as a versatile tool for the design of selective human A3 adenosine receptor antagonists: synthesis, biological evaluation and molecular modeling studies of 2-(hetero)aryl- and 2-carboxy-substituted derivatives. 122
1-Substituted pyrazolo[1,5-c]quinazolines as novel Gly/NMDA receptor antagonists: synthesis, biological evaluation and molecular modeling study 104
2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a New Scaffold to obtain Potent and Selective Human A3 Adenosine Receptor Antagonists: New Insights into the Receptor-Antagonist Recognition† 104
Synthesis and biological evaluation of a new set of pyrazolo[1,5-c]quinazolines as glycine/N-methyl-D-aspartic acid receptor antagonists 102
SYNTHESIS, BINDING STUDIES, AND STRUCTURE ACTIVITY RELATIONSHIPS OF 1-ARYL- AND 2-ARYL[1]BENZOPYRANOPYRAZOL-4-ONES, CENTRAL BENZODIAZEPINE RECEPTOR LIGANDS. 99
SYNTHESIS OF 5H-10,11-DIHYDROPYRAZOLO[5,1-C][1,4]BENZODIAZEPINE DERIVATIVES. II. 93
Synthesis and binding activity of some pyrazolo[1,5-c]quinazolines as tools to verify an optional binding site of a benzodiazepine receptor ligand. 92
SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF 4-CYCLOALKYLAMINO-1,2,4-TRIAZOLO[4,3-A]QUINOXALIN-1-ONE DERIVATIVES AS A1 AND A3 ADENOSINE RECEPTOR ANTAGONISTS. 92
Novel AMPA and kainate receptor antagonists containing the pyrazolo[1,5-c]quinazoline ring system: synthesis and structure-activity relationships 90
SYNTHESIS OF 1,5-DIARYL-3-METHYL-1H-PYRAZOLO[4,5-C]ISOQUINOLINES AND STUDIES OF BINDING TO SPECIFIC PERIPHERAL BENZODIAZEPINE BINDING SITES. 90
4,5-Dihydro-1,2,4-triazolo[1,5-a]quinoxalin-4-ones. Excitatory amino acid antagonists with combined glycine/NMDA and AMPA receptor affinity 90
PYRAZOLO[4,5-C]QUINOLINES. SYNTHESIS AND SPECIFIC INHIBITION OF BENZODIAZEPINE RECEPTOR BINDING. 89
TRICYCLIC HETEROAROMATIC SYSTEMS. SYNTHESIS AND A1 AND A2A ADENOSINE BINDING ACTIVITIES OF SOME 1-ARYL-1,4-DIHYDRO-3-METHYL[1]BENZOPYRANO[2,3-C]PYRAZOL-4-ONES, 1-ARYL-4,9-DIHYDRO-3-METHYL-1H-PYRAZOLO[3,4-B]QUINOLIN-4-ONES, AND 1-ARYL-1H-IMIDAZO[4,5-B]QUINOXALINES. 89
Tricyclic heteroaromatic systems. Synthesis and benzodiazepine receptor affinity of 2-substituted-1-benzopyrano[3,4-d]oxazol-4-ones, -thiazol-4-ones, and –imidazol-4-ones. 89
4-Amino-6-benzylamino-1,2-dihydro-2-phenyl-1,2,4-triazolo[4,3-a] quinoxalin-1-one: a new A2A adenosine receptor antagonist with high selectivity versus A1 receptors. 89
Synthesis and biological evaluation of analogues of 7-chloro-4,5-dihydro-4-oxo-8-(1,2,4-triazol-4-yl)-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylic acid (TQX-173) as novel selective AMPA receptor antagonists 88
TRICYCLIC HETEROAROMATIC SYSTEMS. 5H-1,2,3-TRIAZOLO[5,1-C][1,4]BENZODIAZEPINE. 88
“3-Hydroxy-quinazoline-2,4-dione as a useful scaffold to obtain selective Gly/NMDA and AMPA receptor antagonists” 87
Structure-activity relationship studies of novel pyrazolo[1,5-c][1,3]benzoxazines: synthesis and benzodiazepine receptor affinity. 87
PYRAZOLO[4,5-C]QUINOLINES. 3. SYNTHESIS, RECEPTOR BINDING, AND 13C-NMR STUDY. 87
7-Chloro-4,5-dihydro-8-(1,2,4-triazol-4-yl)-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates as novel highly selective AMPA receptor antagonists. 86
Structural Investigation of the 7-Chloro-3-hydroxy-1H-quinazoline-2,4-dione Scaffold to Obtain AMPA and Kainate Receptor Selective Antagonists. Synthesis, Pharmacological and Molecular Modeling Studies 85
TRICYCLIC HETEROAROMATIC SYSTEMS. 5H-1,2,4-TRIAZOLO[5,1-C][1,4]BENZODIAZEPINE. 84
Synthesis and biological evaluation of a new set of pyrazolo[1,5-c]quinazoline-2-carboxylates as novel excitatory amino acid antagonists 84
Synthesis, glycine/NMDA and AMPA binding activity of some new 2,5,6-trioxopyrazino[1,2,3-de]quinoxalines and of their restricted analogs 2,5-dioxo- and 4,5-dioxoimidazo[1,5,4-de]quinoxalines. 84
SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF 1-AMINOPHTHALAZINIUM SALTS AS GABAA RECEPTOR ANTAGONISTS. 83
TRICYCLIC HETEROCYCLIC SYSTEMS: PYRAZOLO[5',4':4,5]- AND PYRAZOLO[3',4':4,5]PYRANO[2,3-B]PYRIDINE DERIVATIVES. 83
SYNTHESIS OF SOME 2-ARYL-1,2,4-TRIAZOLO[1,5-C][1,3]BENZOXAZIN-5-ONES AS TOOLS TO DEFINE THE ESSENTIAL PHARMACOPHORIC DESCRIPTORS OF A BENZODIAZEPINE RECEPTOR LIGAND. 82
Synthesis and Pharmacological Studies at the Gly/NMDA, AMPA and Kainate Receptors of New Oxazolo[4,5-c]quinolin-4-one derivatives bearing different substituents at position-2 and on the fused benzo ring 82
Synthesis, ligand-receptor modeling studies and pharmacological evaluation of novel 4-modified-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent and selective human A3 adenosine receptor antagonists. 82
4-Amino-2-chloro-1,3,5-triazine: a new metabolite of atrazine by a soil bacterium. 82
1-(3-Aminophenyl)-3-methyl[1]benzopyrano[2,3-c]pyrazol-4-one: a new selective A2 adenosine receptor antagonist. 82
TRICYCLIC HETEROAROMATIC SYSTEMS. 1,2,4-TRIAZOLO[1,5-A]QUINOXALINE. 81
SYNTHESIS OF PYRAZOLO[4,5-D]- AND PYRAZOLO[4,5-C][1]BENZAZEPINE DERIVATIVES. IV. 81
SYNTHESIS OF 5H-PYRAZOLO[5,1-C][1,4]BENZODIAZEPINE. 81
2-Aryl-8-chloro-1,2,4-triazolo[1,5-a]quinoxalin-4-amines as highly potent A1 and A3 adenosine receptor antagonists 81
Pyrido[2,3-e]-1,2,4-triazolo[4,3-a]pyrazin-1-one as a New Scaffold To Develop Potent and Selective Human A3 Adenosine Receptor Antagonists. Synthesis, Pharmacological Evaluation, and Ligand-Receptor Modeling Studies. 81
STRUCTURE-ACTIVITY RELATIONSHIPS OF 1,2,4-TRIAZOLO[1,5-A]QUINOXALINES AND THEIR 1-DEAZA ANALOGS IMIDAZO[1,2-A]QUINOXALINES AT THE BENZODIAZEPINE RECEPTOR. 80
SYNTHESIS AND BINDING STUDY OF PYRAZOLO[4,5-C][1,8]NAPHTHYRIDINES. 79
Atrazine metabolism by Nocardia: elucidation of initial pathway and synthesis of potential metabolites. 78
New 2-Arylpyrazolo[3,4-c]quinoline Derivatives as Potent and Selective Human A3 Adenosine Receptor Antagonists. Synthesis, Pharmacological Evaluation and Ligand-Receptor Modeling Studies. 77
4-Amido-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-ones as New Potent and Selective Human A3 Adenosine Receptor Antagonists. Synthesis, Pharmacological Evaluation and Ligand-Receptor Modeling Studies. 77
TRICYCLIC HETEROAROMATIC SYSTEMS. [1]BENZOPYRANOPYRROL-4-ONES AND [1]BENZOPYRANO-1,2,3-TRIAZOL-4-ONES AS BENZODIAZEPINE RECEPTOR LIGANDS. SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS. 74
Scouting Human A3 Adenosine Receptor Antagonist Binding Mode Using a Molecular Simplification Approach: From Triazoloquinoxaline to a Pyrimidine Skeleton as a Key Study 74
Synthesis of some tricyclic heteroaromatic systems and their A1 and A2a adenosine binding activity. 73
TRICYCLIC HETEROAROMATIC SYSTEMS: [1]BENZOPYRANOPYRAZOL-4-ONES AS BENZODIAZEPINE RECEPTOR LIGANDS. 72
Chemical and biological degradation of primary metabolites of atrazine by a Nocardia strain. 72
Tandem 3D-QSARs Approach as a Valuable Tool To Predict Binding Affinity Data: Design of New Gly/NMDA Receptor Antagonists as a Key Study. 71
THE CORRECT SYNTHESIS OF 2,3-DIHYDRO-2-ARYL-4-R-[1]BENZOPYRANO[4,3-C]PYRAZOLE-3-ONES. 71
. PYRROLNITRIN ANALOGS. XII. SYNTHESIS AND BIOLOGICAL ACTIVITY OF SOME PYRAZOLE CARBOXYLIC ACIDS. 70
Synthesis, structure-affinity relationships, and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists. 69
Synthesis and Structure-Activity Relationships of a new set of 2-arylpyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists. 69
Tricyclic heteroaromatic systems. 1,2,4-triazolo[4,3-a]quinoxalines and 1,2,4-triazino[4,3-a]quinoxalines: synthesis and central benzodiazepine receptor activity. 69
Tricyclic heteroaromatic systems. Pyrazolo[3,4-c]quinolin-4-ones and pyrazolo[3,4-c]quinoline-1,4-diones: synthesis and benzodiazepine receptor activity. 68
Benzodiazepine binding activity of some tricyclic heteroarometic systems to define the hydrogen bonding strength of the proton donors of the receptor site. 67
Synthesis of pyrrolnitrin analogs. III. Preparation and antibacterial properties of 1,3-diaryl-substituted maleimides. 67
Synthesis and structure-activity relationships of a new set of 1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as adenosine receptor antagonists. 66
Pharmacological characterization of some selected 4,5-dihydro-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates and 3-hydroxyquinazoline-2,4-diones as (S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionic acid receptor antagonists. 65
Antiblastic agents. XXXVI. Anthramycin and analogous compounds. 1. Synthesis of 10,11-dihydro-5H-pyrrolo-[2,1-s][1,4]-benzodiazepine. 64
NOVEL ADENOSINE RECEPTOR LIGANDS: 1,3-DISUBSTITUTED[1]BENZOPYRANO[2,3-C]PYRAZOL-4-ONES. SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS. 64
Novel potent and highly selective human A3 adenosine receptor antagonists belonging to the 4-amido-2-arylpyrazolo[3,4-c]quinoline series: molecular docking analysis and pharmacological studies 64
Synthesis of 4-amino-6-(hetero)arylalkylamino-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent A2A adenosine receptor antagonists. 63
TRICYCLIC HETEROAROMATIC SYSTEMS. 1,2,3,4-TETRAHYDROPYRAZOLO[4,3-C][1]BENZAZEPIN-1-ONES AS POTENTIAL ANTITUMOR AGENTS. 62
TRICYCLIC HETEROAROMATIC SYSTEMS: SYNTHESIS, [3H]FLUNITRAZEPAM BRAIN MEMBRANE BINDING INHIBITION, AND STRUCTURE-ACTIVITY RELATIONSHIPS OF 2,3-DIHYDRO-2-ARYL-4-R-[1]BENZOPYRANO[4,3-C]PYRAZOL-3-ONES. 62
PYRROLNITRIN ANALOGS. X. SYNTHESIS AND BIOLOGICAL ACTIVITY OF 1-CHLOROPHENYL-3- OR -5-NITROPHENYLPYRAZOLE-4-CARBOXYLIC ACIDS. 60
SYNTHESIS AND CARBON-13 NMR STUDY OF PYRAZOLO[4,5-C]- AND PYRAZOLO[4,3-C][1]BENZAZEPINES. III. 59
REACTION OF 1-AMINOPHTHALAZINES WITH A-HALOCARBONYL COMPOUNDS: IMIDAZO-2,1-A]PHTHALAZINES AND THEIR BENZODIAZEPINE RECEPTOR ACTIVITIES. 59
PYRROLNITRIN ANALOGS. IX. SYNTHESIS AND BIOLOGICAL ACTIVITY OF 1-TOLYL-3-NITROPHENYL-5-METHYLPYRAZOLE-4-CARBOXYLIC ACIDS AND 1-TOLYL-3-METHYL-5-NITROPHENYLPYRAZOLE-4-CARBOXYLIC ACIDS. FARMACO, EDIZIONE SCIENTIFICA (1984), 39(10), 888-900. 59
TRICYCLIC HETEROAROMATIC SYSTEMS PYRAZOLO[1,5-A]QUINOXALINES: SYNTHESIS AND BENZODIAZEPINE RECEPTOR ACTIVITY. 57
Synthesis of 3-substituted 1,2,4,5-tetrahydro-2,5-dioxo-3H-1,4-benzodiazepines. 57
STUDY OF SUBSTANCES WITH ANTITUMOR ACTIVITY. LXIV. DERIVATIVES OF 9H-PYRROLO[1,2-A]INDOLE. 55
PYRROLNITRIN ANALOGS. VIII. SYNTHESIS AND ANTIBACTERIAL ACTIVITY OF NEW 1,4- AND 1,5-DIARYLPYRROLES. 54
Pyrrolnitrin analogs. I. Reaction of N-(p-nitrophenacyl)aniline with acetoacetic ester. 54
Tricyclic heteroaromatic systems. Synthesis and benzodiazepine binding activity of 1-substituted-3-methyl- and 3-phenylpyrazolo[4,5-c]quinolin-4-ones. 54
Synthesis and biological evaluation of a series of quinazoline-2-carboxylic acids and quinazolin-2,4-diones as glycine-NMDA antagonists: a pharmacophore model based approach. 50
DIPYRAZOLO[5,4-B:3',4'-D]PYRIDINES. SYNTHESIS, INHIBITION OF BENZODIAZEPINE RECEPTOR BINDING AND STRUCTURE-ACTIVITY RELATIONSHIPS. 49
Antiblastic substances. LII. Tylophorine analogs. 1. Synthesis and cytostotic and cytotoxic activity of 4-(3,4-dimethoxyphenyl)piperidine. 49
Pyrrolnitrin analogs. V. Knorr's pyrrole condensation between N-(4-nitrophenacyl)-3,5-dimethylaniline and ethyl acetoacetate. 49
Synthesis of 2-substituted-3,4-dihydro-3-oxo-6,8-dichloro-2H-1,4-benzothiazin-1,1-dioxides and 1-oxides as glycine-NMDA receptor antagonists. 49
PYRROLNITRIN ANALOGS. VII. ETHYL 1,4- AND 1,5-DIARYL-2-METHYLPYRROLE-3-CARBOXYLATES FROM PHENACYLARYLAMINES AND ETHYL ACETOACETATE. 48
SYNTHESIS AND BINDING STUDIES OF 1-ARYLPYRAZOLO[4,5-C]- AND 2-ARYLPYRAZOLO[4,3-C]QUINOLIN-4-ONES. 47
Synthesis and A1 and A2A binding activity of some pyrano[2,3-c]pyrazol-4-ones. 47
TRICYCLIC HETEROAROMATIC SYSTEMS. SYNTHESIS OF 1,3 AND 1,2 DISUBSTITUTED [1]BENZOPYRANO[4,3-B]PYRROL-4-ONES AND STRUCTURE-ACTIVITY RELATIONSHIPS AS BENZODIAZEPINE RECEPTOR LIGANDS. 47
STUDY OF SUBSTANCES WITH ANTITUMOR ACTIVITY. LXV. THE 2-(4-NITROBENZOYL)INDOLIN-3-ONES BY CYCLIZATION OF N-ACETYL- N-(4-NITROPHENACYL)ANTHANILIC METHYL ESTER DERIVATIVES. 46
Psychotropic-active compounds. I. Synthesis of 5-phenylpyrrolo[2,1-d][1,5]benzothiazepine 6,6-dioxide and 1,4 dioxo-1,2,3,3a,4,5-hexahydro-5-phenylpyrrolo[2,1-d][1,5]benzothiazepine 6,6-dioxide, derivatives of a new heterocyclic system 46
Psychotropic compounds. II. Synthesis of derivatives of 5-phenylpyrrolo[2,1-d][1,5]benzothiazepine 6,6-dioxide and 1,2,3,3a,4,5-hexahydro-5-phenylpyrrolo[2,1-d][1,5]benzothiazepine-1,4-dione 6,6-dioxide and their pharmacological properties. 46
Study of nitrogenous heterocyclic compounds. Note XI. A new synthesis of 3H-benz[e]indole and its derivatives. 46
Synthesis, Ionotropic glutamate receptor binding affinity and structure-activity relationships of a new set of 4,5-dihydro-8-heteroaryl-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates analogue of TQX-173 45
Nitrogen heterocycles. IX. Synthesis of 5-hydroxy-2,4-dicarbethoxypyrroles. 45
TRICYCLIC HETEROAROMATIC SYSTEMS. 2-PHENYL-1,2,4-TRIAZOLO[1,5-C][1,3]BENZOXAZIN-5-ONE: A NOVEL BENZODIAZEPINE RECEPTOR LIGAND. 44
Synthesis and biological activity of some 3-(pyrazol-1'-yl)indazole derivatives 44
Study on antiblastic substances. LXI. Synthesis of derivatives of 6-amino- and 7-amino-9-oxo-9H-pyrrolo[1,2-a]indole. 44
Compounds with psychotropic activity. III. Synthesis of a new heterocyclic system. 4H-pyrrolo[2,1-c][1,4]benzothiazine. 43
Synthesis of a set of ethyl 1-carbamoyl-3-oxoquinoxaline-2-carboxylates and their constrained analogue imidazo[1,5-a]quinoxalines-1,3,4-triones as selective Glycine/NMDA receptor antagonists. 43
TRICYCLIC HETEROAROMATIC SYSTEMS 1,2,4-TRIAZOLO[1,5-A]QUINOXALINES: SYNTHESIS AND BENZODIAZEPINE RECEPTOR ACTIVITY. 42
Totale 7.513
Categoria #
all - tutte 19.652
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.652


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019593 0 0 0 0 0 0 0 0 5 111 258 219
2019/20201.670 149 169 33 205 133 228 142 241 127 59 149 35
2020/20211.513 104 38 174 129 18 216 19 128 83 183 72 349
2021/2022677 25 87 23 47 23 26 26 54 26 20 149 171
2022/20231.966 181 225 77 133 219 381 337 100 237 6 44 26
2023/2024711 34 99 132 58 36 152 14 174 12 0 0 0
Totale 8.149